Schreiner Group has expanded its Jinshan site to enahnce its medical label producing capabilities, with the novel site offering nearly 57,048 sqft of space. The expansion had become necessary due to the company’s consistent growth.
“Due to our local production, we can deliver products to our customers fast and reliably,” says CEO Roland Schreiner. “As a result, we not only avoid long shipping routes and offer short delivery times, but also show a presence on the Chinese market that’s not focused on exports.”
Another positive aspect is the fact that Jinshan is staffed almost exclusively by Chinese employees, with employee retention being high in the last few years.
In addition, the promotion of two Chinese colleagues to leadership roles is a visible sign that the company believes in its local employees and invests in them. That is an incentive for new employees as well because growth continues.
“As a result of our move to Jinshan a little more than a year and a half ago, we have an area that’s almost three times as large as the one we had before—and that’s exactly the space we need for further growth,” says Thomas Köberlein, President of Schreiner ProTech and Managing Director of Schreiner Group China. “The Chinese domestic market is huge and offers plenty of potential in our core segments, Mobility and Healthcare. We’re in a good position locally with both Schreiner ProTech and Schreiner MediPharm and can therefore gradually expand our market position.”
The local production enables the development and manufacturing of tailored solutions directly on the ground, which not only strengthens the company’s global competitiveness but also its ties to the local markets. That is a significant element of Schreiner Group’s internationalisation strategy.
Due to its growth potential and opportunities, the Jinshan location is going to continue to contribute to the robustness of Schreiner Group as a whole in 2024.
